Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Glaucoma Risk Reduction as a Secondary Benefit of Glucagon-like Peptide-1 Receptor Agonists: A Review of Emerging Evidence.

Journal of current glaucoma practice·2026

Same author

Bridging Genomics and Practice: Rethinking Genetic Counseling in Glaucoma.

Journal of current glaucoma practice·2026

Same author

Preserflo MicroShunt in refractory glaucoma: multicentre european results with up to three years of follow-up.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026

Same author

Three-year outcomes of preserflo MicroShunt with mitomycin C for uveitic glaucoma.

Indian journal of ophthalmology·2025

Same author

Evaluating the ease of use and clinical applicability of the Melbourne Rapid Field for visual field testing: A real-world experience.

Indian journal of ophthalmology·2025

Same author

Weighted Quality of Life in Glaucoma Patients with Advanced Disease.

Journal of current glaucoma practice·2025

Search research articles

Related Experiment Video

Updated: Jul 22, 2025

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Can We Ever Win with a Suprachoroidal Implant?

Leon Au¹, Shibal Bhartiya²

¹Department of Ophthalmology, Manchester Royal Eye Hospital, Manchester, United Kingdom.

Journal of Current Glaucoma Practice

|July 24, 2023

Summary

Suprachoroidal implants show potential for glaucoma management but face challenges. Further research is needed to determine their long-term efficacy and safety in winning the battle against glaucoma.

Area of Science:

Ophthalmology
Glaucoma Research
Ocular Implants

Background:

Glaucoma is a leading cause of irreversible blindness worldwide.

More Related Videos

Techniques for Processing Eyes Implanted With a Retinal Prosthesis for Localized Histopathological Analysis

Techniques for Processing Eyes Implanted With a Retinal Prosthesis for Localized Histopathological Analysis

Published on: August 2, 2013

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Published on: November 11, 2022

Related Experiment Videos

Last Updated: Jul 22, 2025

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Techniques for Processing Eyes Implanted With a Retinal Prosthesis for Localized Histopathological Analysis

Techniques for Processing Eyes Implanted With a Retinal Prosthesis for Localized Histopathological Analysis

Published on: August 2, 2013

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Published on: November 11, 2022

Current treatments aim to lower intraocular pressure (IOP) but have limitations.

Suprachoroidal drug delivery presents a novel approach for sustained IOP control.